Luis E Zambrana1, Annika M Weber1, Erica C Borresen1, Iman Zarei1, Johann Perez2, Claudia Perez2, Iker Rodríguez1, Sylvia Becker-Dreps3, Lijuan Yuan4, Samuel Vilchez2, Elizabeth P Ryan1. 1. Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO, USA. 2. Center of Infectious Diseases, Department of Microbiology and Parasitology, Faculty of Medical Sciences, National Autonomous University of Nicaragua, León (UNAN-León), León, Nicaragua. 3. Departments of Family Medicine and Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 4. Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA.
Abstract
BACKGROUND: Environmental enteric dysfunction (EED) is associated with chronic gut inflammation affecting nutrient absorption and development of children, primarily in low- and middle-income countries. Several studies have shown that rice bran (RB) supplementation provides nutrients and modulates gut inflammation, which may reduce risk for undernutrition. OBJECTIVE: The aim was to evaluate the effect of daily RB dietary supplementation for 6 mo on serum biomarkers in weaning infants and associated changes in serum and stool metabolites. METHODS: A 6-mo randomized-controlled dietary intervention was conducted in a cohort of weaning 6-mo-old infants in León, Nicaragua. Anthropometric indices were obtained at 6, 8, and 12 mo. Serum and stool ionomics and metabolomics were completed at the end of the 6-mo intervention using inductively coupled plasma MS and ultra-high performance LC-tandem MS. The ɑ1-acid glycoprotein, C-reactive protein, and glucagon-like peptide 2 (GLP-2) serum EED biomarkers were measured by ELISA. RESULTS: Twenty-four infants in the control group and 23 in the RB group successfully completed the 6-mo dietary intervention with 90% dietary compliance. RB participants had higher concentrations of GLP-2 as compared with control participants at 12 mo [median (IQR): 743.53 (380.54) pg/mL vs. 592.50 (223.59) pg/mL; P = 0.04]. Metabolite profiles showed significant fold differences of 39 serum metabolites and 44 stool metabolites from infants consuming RB compared with control, and with significant metabolic pathway enrichment scores of 4.7 for the tryptophan metabolic pathway, 5.7 for polyamine metabolism, and 5.7 for the fatty acid/acylcholine metabolic pathway in the RB group. No differences were detected in serum and stool trace elements or heavy metals following daily RB intake for 6 mo. CONCLUSIONS: RB consumption influences a suite of metabolites associated with growth promotion and development, while also supporting nutrient absorption as measured by changes in serum GLP-2 in Nicaraguan infants. This clinical trial was registered at https://clinicaltrials.gov as NCT02615886.
BACKGROUND: Environmental enteric dysfunction (EED) is associated with chronic gut inflammation affecting nutrient absorption and development of children, primarily in low- and middle-income countries. Several studies have shown that rice bran (RB) supplementation provides nutrients and modulates gut inflammation, which may reduce risk for undernutrition. OBJECTIVE: The aim was to evaluate the effect of daily RB dietary supplementation for 6 mo on serum biomarkers in weaning infants and associated changes in serum and stool metabolites. METHODS: A 6-mo randomized-controlled dietary intervention was conducted in a cohort of weaning 6-mo-old infants in León, Nicaragua. Anthropometric indices were obtained at 6, 8, and 12 mo. Serum and stool ionomics and metabolomics were completed at the end of the 6-mo intervention using inductively coupled plasma MS and ultra-high performance LC-tandem MS. The ɑ1-acid glycoprotein, C-reactive protein, and glucagon-like peptide 2 (GLP-2) serum EED biomarkers were measured by ELISA. RESULTS: Twenty-four infants in the control group and 23 in the RB group successfully completed the 6-mo dietary intervention with 90% dietary compliance. RB participants had higher concentrations of GLP-2 as compared with control participants at 12 mo [median (IQR): 743.53 (380.54) pg/mL vs. 592.50 (223.59) pg/mL; P = 0.04]. Metabolite profiles showed significant fold differences of 39 serum metabolites and 44 stool metabolites from infants consuming RB compared with control, and with significant metabolic pathway enrichment scores of 4.7 for the tryptophan metabolic pathway, 5.7 for polyamine metabolism, and 5.7 for the fatty acid/acylcholine metabolic pathway in the RB group. No differences were detected in serum and stool trace elements or heavy metals following daily RB intake for 6 mo. CONCLUSIONS: RB consumption influences a suite of metabolites associated with growth promotion and development, while also supporting nutrient absorption as measured by changes in serum GLP-2 in Nicaraguan infants. This clinical trial was registered at https://clinicaltrials.gov as NCT02615886.
Authors: P Fitzgerald; M Cassidy Eugene; G Clarke; P Scully; S Barry; M M Quigley Eamonn; F Shanahan; J Cryan; G Dinan Timothy Journal: Neurogastroenterol Motil Date: 2008-09-24 Impact factor: 3.598
Authors: Dustin G Brown; Sangeeta Rao; Tiffany L Weir; Joanne O'Malia; Marlon Bazan; Regina J Brown; Elizabeth P Ryan Journal: Cancer Metab Date: 2016-06-06
Authors: Marjo Tuomainen; Jaana Lindström; Marko Lehtonen; Seppo Auriola; Jussi Pihlajamäki; Markku Peltonen; Jaakko Tuomilehto; Matti Uusitupa; Vanessa D de Mello; Kati Hanhineva Journal: Nutr Diabetes Date: 2018-05-25 Impact factor: 5.097
Authors: Margaret N Kosek; Estomih Mduma; Peter S Kosek; Gwenyth O Lee; Erling Svensen; William K Y Pan; Maribel Paredes Olortegui; Jay H Bream; Crystal Patil; Cesar Ramal Asayag; Graciela Meza Sanchez; Laura E Caulfield; Jean Gratz; Pablo Peñataro Yori Journal: Am J Trop Med Hyg Date: 2016-08-08 Impact factor: 2.345
Authors: Jea Woo Kang; Xinyu Tang; Charles J Walton; Mark J Brown; Rachel A Brewer; Rolando L Maddela; Jack Jingyuan Zheng; Joanne K Agus; Angela M Zivkovic Journal: Front Nutr Date: 2022-06-17
Authors: Brigitte A Pfluger; Hillary V Smith; Annika M Weber; Hend Ibrahim; Lassina Doumbia; Abdoulaye Bore; Alima Cissoko; Seydou Douyon; Karim Kone; Lansana Sangare; Ababacar Maiga; Ousmane A Koita; Kelli Goodman; Anne M Evans; Elizabeth P Ryan Journal: Nutrients Date: 2022-01-30 Impact factor: 5.717